Shui‐Juan Wang
China Pharmaceutical University(CN)Nanjing University(CN)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Diet, Metabolism, and Disease, Lipid metabolism and disorders, Liver physiology and pathology, Gut microbiota and health
Most-Cited Works
- → Dietary fructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: a benefit of short-chain fatty acids(2019)278 cited
- → Quercetin and allopurinol reduce liver thioredoxin‐interacting protein to alleviate inflammation and lipid accumulation in diabetic rats(2013)190 cited
- → Magnesium isoglycyrrhizinate blocks fructose-induced hepatic NF-κB/NLRP3 inflammasome activation and lipid metabolism disorder(2017)64 cited
- → Magnesium isoglycyrrhizinate ameliorates high fructose-induced liver fibrosis in rat by increasing miR-375-3p to suppress JAK2/STAT3 pathway and TGF-β1/Smad signaling(2018)60 cited
- → Chaihu-shugan san inhibits inflammatory response to improve insulin signaling in liver and prefrontal cortex of CUMS rats with glucose intolerance(2018)50 cited
- → Dataset on assessment of magnesium isoglycyrrhizinate injection for dairy diet and body weight in fructose-induced metabolic syndrome of rats(2018)1 cited
- → Author Correction: Magnesium isoglycyrrhizinate ameliorates high fructose-induced liver fibrosis in rat by increasing miR-375-3p to suppress JAK2/STAT3 pathway and TGF-β1/Smad signaling(2021)1 cited
- → Corrigendum to “Magnesium isoglycyrrhizinate blocks fructose-induced hepatic NF-κB/NLRP3 inflammasome activation and lipid metabolism disorder” [Eur. J. Pharmacol. 15 (2017) 809: 141–150](2021)
- → Correction: magnesium isoglycyrrhizinate ameliorates high fructose-induced liver fibrosis in rat by increasing miR-375-3p to suppress JAK2/STAT3 pathway and TGF-β1/Smad signaling(2025)